PT Millennium Pharmacon International Tbk (SDPC.JK)

139.00 -1.00 (-0.71%) At close: 03:39PM WIB

PT Millennium Pharmacon International Tbk

Crown Bungur Arteri
2-4th Floors Jl. Sultan Iskandar Muda No.18 Jl. Bungur No.1, Kebayoran Lama
Jakarta Selatan 12220
Indonesia
62 21 270 85961
https://www.mpi-indonesia.co.id

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 1,154

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ahmad Bin Abu Bakar	President Director	N/A	N/A	1969
Yungkis Sucandra	Head of Finance & Accounting Unit	N/A	N/A	N/A
Puji Hartono	Head of Business & Operation Unit	N/A	N/A	N/A
Yuni Arrivani	Deputy Senior Manager of HRGA & Legal	N/A	N/A	N/A
Dedi K. Martadiredja	Senior Manager of Sales	N/A	N/A	N/A
- Morsela	Manager of Marketing	N/A	N/A	N/A
Mr. Mohamad Fazly Bin Hassan	Finance Director & Director	N/A	N/A	1974
Aris Sulistyanto	Head of the Internal Audit	N/A	N/A	1989
Ms. Olga Indria Bolang	Corporate Secretary	N/A	N/A	1977

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.

Description

PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines and medical devices in Indonesia. As of December 31, 2022, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.

Corporate governance

PT Millennium Pharmacon International Tbk’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.